The Trupanion Inc (TRUP) COO Ian Moffat Sells 8,552 Shares

The Trupanion Inc (TRUP) COO Ian Moffat Sells 8,552 Shares

Shares of Trupanion Inc (TRUP) traded down 0.35% during trading on Tuesday, hitting $22.81. The stock had a trading volume of 92,268 shares. The stock’s 50-day moving average is $22.63 and its 200-day moving average is $17.84. Trupanion Inc has a 12-month low of $13.71 and a 12-month high of $25.00. The stock’s market capitalization is $684.19 million.

Trupanion Inc (NYSE:TRUP) COO Ian Moffat sold 8,552 shares of the firm’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $23.20, for a total value of $198,406.40. Following the completion of the sale, the chief operating officer now owns 8,552 shares of the company’s stock, valued at approximately $198,406.40. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Trupanion (NYSE:TRUP) last issued its quarterly earnings data on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. Trupanion had a negative return on equity of 13.24% and a negative net margin of 2.71%. The company had revenue of $58.30 million during the quarter, compared to analysts’ expectations of $57.58 million. During the same quarter in the previous year, the company posted ($0.03) earnings per share. The business’s revenue was up 27.3% on a year-over-year basis. Analysts predict that Trupanion Inc will post ($0.12) EPS for the current fiscal year.

A number of analysts have commented on the company. TheStreet upgraded Trupanion from a “d” rating to a “c-” rating in a research report on Monday, July 17th. BidaskClub downgraded Trupanion from a “buy” rating to a “hold” rating in a research report on Tuesday. Canaccord Genuity raised their price objective on Trupanion from $28.00 to $29.00 and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. Zacks Investment Research upgraded Trupanion from a “sell” rating to a “hold” rating in a research report on Tuesday, July 18th. Finally, Cowen and Company reiterated a “buy” rating and issued a $19.00 price objective on shares of Trupanion in a research report on Friday, July 14th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Trupanion presently has a consensus rating of “Buy” and an average target price of $24.50.

Several large investors have recently modified their holdings of TRUP. Nine Ten Capital Management LLC boosted its stake in shares of Trupanion by 53.4% in the first quarter. Nine Ten Capital Management LLC now owns 1,112,380 shares of the financial services provider’s stock valued at $15,818,000 after buying an additional 387,320 shares during the period. Wellington Management Group LLP boosted its stake in shares of Trupanion by 71.8% in the first quarter. Wellington Management Group LLP now owns 929,226 shares of the financial services provider’s stock valued at $13,213,000 after buying an additional 388,226 shares during the period. Vanguard Group Inc. boosted its stake in shares of Trupanion by 3.7% in the first quarter. Vanguard Group Inc. now owns 650,459 shares of the financial services provider’s stock valued at $9,249,000 after buying an additional 23,419 shares during the period. Handelsbanken Fonder AB boosted its stake in shares of Trupanion by 17.8% in the second quarter. Handelsbanken Fonder AB now owns 530,000 shares of the financial services provider’s stock valued at $11,861,000 after buying an additional 80,000 shares during the period. Finally, Morgan Stanley boosted its stake in shares of Trupanion by 56.2% in the first quarter. Morgan Stanley now owns 305,364 shares of the financial services provider’s stock valued at $4,343,000 after buying an additional 109,904 shares during the period.

Trupanion Company Profile

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Related posts

Leave a Comment